Apyx Medical CorporationAPYXNASDAQ
Loading
Year-over-year earnings per share growth rate
5Y CAGR
-9.0%/yr
Long-term compound
Percentile
P74
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 37.14% |
| Q3 2025 | 47.20% |
| Q2 2025 | 22.67% |
| Q1 2025 | 0.00% |
| Q4 2024 | 14.29% |
| Q3 2024 | 26.32% |
| Q2 2024 | 13.64% |
| Q1 2024 | 21.43% |
| Q4 2023 | -115.38% |
| Q3 2023 | -352.96% |
| Q2 2023 | 71.30% |
| Q1 2023 | 41.18% |
| Q4 2022 | 0.00% |
| Q3 2022 | -6.25% |
| Q2 2022 | 5.88% |
| Q1 2022 | -191.60% |
| Q4 2021 | 51.42% |
| Q3 2021 | 0.00% |
| Q2 2021 | 14.29% |
| Q1 2021 | -213.90% |
| Q4 2020 | 59.45% |
| Q3 2020 | 21.43% |
| Q2 2020 | -145.18% |
| Q1 2020 | 64.31% |
| Q4 2019 | -23.08% |
| Q3 2019 | 0.00% |
| Q2 2019 | 7.14% |
| Q1 2019 | -16.67% |
| Q4 2018 | -105.83% |
| Q3 2018 | 20700.00% |
| Q2 2018 | 64.79% |
| Q1 2018 | -10.94% |
| Q4 2017 | 36.16% |
| Q3 2017 | 8.03% |
| Q2 2017 | 20.15% |
| Q1 2017 | -198.36% |
| Q4 2016 | 48.60% |
| Q3 2016 | -78.00% |
| Q2 2016 | 72.18% |
| Q1 2016 | -38.00% |